Aperio Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $49.4M | Sell |
1,016,032
-113,365
| -10% | -$5.59M | 0.15% | 135 |
|
|
2020
Q3 | $56.7M | Sell |
1,129,397
-38,104
| -3% | -$1.96M | 0.19% | 94 |
|
|
2020
Q2 | $59.6M | Sell |
1,167,501
-21,308
| -2% | -$1.04M | 0.22% | 83 |
|
|
2020
Q1 | $52M | Buy |
1,188,809
+124,731
| +12% | +$5.97M | 0.23% | 76 |
|
|
2019
Q4 | $53.4M | Buy |
1,064,078
+31,604
| +3% | +$1.48M | 0.19% | 103 |
|
|
2019
Q3 | $47.8M | Sell |
1,032,474
-83,667
| -7% | -$3.61M | 0.19% | 106 |
|
|
2019
Q2 | $48.3M | Buy |
1,116,141
+9,247
| +0.8% | +$393K | 0.2% | 103 |
|
|
2019
Q1 | $49M | Buy |
1,106,894
+3,433
| +0.3% | +$147K | 0.21% | 91 |
|
|
2018
Q4 | $47.9M | Buy |
1,103,461
+143,301
| +15% | +$6.32M | 0.24% | 82 |
|
|
2018
Q3 | $42.9M | Buy |
960,160
+152,734
| +19% | +$6.52M | 0.19% | 118 |
|
|
2018
Q2 | $32.3M | Sell |
807,426
-28,883
| -3% | -$1.14M | 0.15% | 150 |
|
|
2018
Q1 | $33.5M | Buy |
836,309
+51,555
| +7% | +$2.15M | 0.17% | 138 |
|
|
2017
Q4 | $33.7M | Buy |
784,754
+1,760
| +0.2% | +$81.2K | 0.17% | 129 |
|
|
2017
Q3 | $39M | Buy |
782,994
+101,764
| +15% | +$4.92M | 0.22% | 97 |
|
|
2017
Q2 | $32.6M | Buy |
681,230
+102,804
| +18% | +$4.91M | 0.2% | 107 |
|
|
2017
Q1 | $26.2M | Buy |
578,426
+52,906
| +10% | +$2.24M | 0.18% | 129 |
|
|
2016
Q4 | $21.3M | Sell |
525,520
-215,554
| -29% | -$8.49M | 0.16% | 140 |
|
|
2016
Q3 | $28.3M | Buy |
741,074
+23,772
| +3% | +$954K | 0.2% | 110 |
|
|
2016
Q2 | $30M | Sell |
717,302
-31,947
| -4% | -$1.31M | 0.23% | 99 |
|
|
2016
Q1 | $30.1M | Buy |
749,249
+247,314
| +49% | +$9.94M | 0.26% | 82 |
|
|
2015
Q4 | $21.4M | Sell |
501,935
-239,011
| -32% | -$11M | 0.2% | 121 |
|
|
2015
Q3 | $35.2M | Buy |
740,946
+88,514
| +14% | +$4.51M | 0.36% | 53 |
|
|
2015
Q2 | $32.3M | Buy |
652,432
+43,468
| +7% | +$2.2M | 0.33% | 62 |
|
|
2015
Q1 | $30.1M | Buy |
608,964
+287,022
| +89% | +$13.7M | 0.34% | 64 |
|
|
2014
Q4 | $14.7M | Sell |
321,942
-138,475
| -30% | -$6.72M | 0.18% | 131 |
|
|
2014
Q3 | $26M | Buy |
460,417
+29,778
| +7% | +$1.6M | 0.35% | 54 |
|
|
2014
Q2 | $22.9M | Buy |
430,639
+83,454
| +24% | +$4.43M | 0.33% | 57 |
|
|
2014
Q1 | $18.2M | Buy |
+347,185
| New | +$17.6M | 0.26% | 71 |
|
|
2013
Q4 | – | Sell |
-273,265
| Closed | -$14.1M | – | 79 |
|
|
2013
Q3 | $13.8M | Buy |
273,265
+33,956
| +14% | +$1.73M | 0.27% | 68 |
|
|
2013
Q2 | $12.3M | Buy |
+239,309
| New | +$12.8M | 0.29% | 62 |
|
Other funds holding SNY
Aperio Group's SNY Position: Q4 2020 in Review
Aperio Group reduced its Sanofi (SNY) stake by 10% in Q4 2020, selling an estimated $5.59M and leaving 1,016,032 shares worth $49.4M. The position accounts for 0.15% of the portfolio, ranked #135.
Aperio Group first reported a position in SNY in Q2 2013 and has held it in 30 quarters since. The position peaked at $59.6M in Q2 2020. 603 funds tracked by Wall St. Rank hold SNY as of Q4 2020.
- Aperio Group held 1,016,032 shares of Sanofi worth $49.4M as of Q4 2020.
- Aperio Group sold 113,365 Sanofi shares in Q4 2020, an estimated $5.59M.
- Sanofi made up 0.15% of Aperio Group's portfolio in Q4 2020, its #135 holding.
- Aperio Group first reported a position in Sanofi in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Sanofi position peaked at $59.6M in Q2 2020.
- 603 funds tracked by Wall St. Rank held Sanofi as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.